Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
Authors
Keywords
-
Journal
Alzheimers & Dementia
Volume 16, Issue 5, Pages 750-758
Publisher
Wiley
Online
2020-04-13
DOI
10.1002/alz.12069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
- (2019) Fiona Heeman et al. EJNMMI Research
- Current and emerging avenues for Alzheimer's disease drug targets
- (2019) R. Loera‐Valencia et al. JOURNAL OF INTERNAL MEDICINE
- Subthreshold amyloid and its biological and clinical meaning
- (2019) Gérard N. Bischof et al. NEUROLOGY
- Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
- (2019) Niklas Mattsson et al. JAMA Neurology
- 18F-FDG PET, the early phases and the delivery rate of 18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against 15O-H2O PET
- (2019) Julie Ottoy et al. Alzheimers & Dementia
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- (2019) Arno de Wilde et al. Alzheimers Research & Therapy
- Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors
- (2019) Hannah Stocker et al. Alzheimers & Dementia
- Detection of amyloid beta peptides in body fluids for the diagnosis of alzheimer’s disease: Where do we stand?
- (2019) Bhavana Veerabhadrappa et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Rate of β-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials
- (2018) Tengfei Guo et al. Alzheimers & Dementia
- PET staging of amyloidosis using striatum
- (2018) Bernard J. Hanseeuw et al. Alzheimers & Dementia
- Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future
- (2018) Jeffrey Cummings et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid pathology in the progression to mild cognitive impairment
- (2018) Philip S. Insel et al. NEUROBIOLOGY OF AGING
- Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
- (2018) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- The EMIF-AD PreclinAD study: study design and baseline cohort overview
- (2018) Elles Konijnenberg et al. Alzheimers Research & Therapy
- Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
- (2018) Lyduine Collij et al. JOURNAL OF NUCLEAR MEDICINE
- Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
- (2018) Michelle E. Farrell et al. NEUROLOGY
- Elevated Brain Amyloid in Cognitively Normal Individuals—Reply
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
- (2017) Michael C. Donohue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Forward to the Past: The Case for Quantitative PET Imaging
- (2017) Adriaan A. Lammertsma JOURNAL OF NUCLEAR MEDICINE
- In vivo staging of regional amyloid deposition
- (2017) Michel J. Grothe et al. NEUROLOGY
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials
- (2016) Rik Vandenberghe et al. Alzheimers Research & Therapy
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform
- (2015) Elisabetta Vaudano et al. Alzheimers & Dementia
- [ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology
- (2015) Dietmar Rudolf Thal et al. Alzheimers & Dementia
- The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
- (2015) Mark E. Schmidt et al. Alzheimers & Dementia
- Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation
- (2015) Sylvia Villeneuve et al. BRAIN
- Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET
- (2015) Y. J. Chen et al. JOURNAL OF NUCLEAR MEDICINE
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal Amyloid Imaging Using 11C-PiB: Methodologic Considerations
- (2013) B. N. M. van Berckel et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study
- (2011) Henryk Barthel et al. LANCET NEUROLOGY
- Phase 1 Study of the Pittsburgh Compound B Derivative 18F-Flutemetamol in Healthy Volunteers and Patients with Probable Alzheimer Disease
- (2009) N. Nelissen et al. JOURNAL OF NUCLEAR MEDICINE
- LEAP: Learning embeddings for atlas propagation
- (2009) Robin Wolz et al. NEUROIMAGE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started